CS Paper Radar

Patient, Place, Prior (P$^3$): What Counts as Personalization in Medical World Models?

Xingrui Gu, Hanxue Gu, Yuxiang Zhang, Yang Yang

cs.LG cs.AI ·submitted 2026-10-06 22:45 UTC · v1

Abstract

Longitudinal models forecast how a patient's imaging state evolves, but accuracy does not show whether the patient's observed trajectory drives the prediction. A population-average forecast may be useful but cannot establish a patient-specific world-model claim. We introduce Patient, Place, Prior (P$^3$), an audit asking whether a forecast benefits from the patient's longitudinal imaging history (Patient), benefits from patient-matched externally supplied spatial support (Place), and gains predictive value beyond a population-average prediction under matched support and context (Prior). We also propose Cancer JEPA, a one-step model that forecasts frozen representations of future breast dynamic contrast-enhanced MRI examinations during neoadjuvant therapy. It adds a lesion-constrained neural correction, trained with an occlusion-based latent objective, to a patient-conditioned low-complexity reduced-rank regression baseline. This factorization permits a post-hoc P$^3$ audit of the frozen model. In a validation cohort previously used in development, forecast error is lower when the neural correction receives the patient's history rather than another patient's and patient-matched lesion occupancy maps rather than substituted maps. However, the descriptive 95% interval comparing the correction computed from patient history with the population-average neural correction includes zero. P$^3$ thus separates input use from evidence of patient-specific predictive value beyond a population-level pattern.

Comment
12 pages, 1 figure, 2 tables

Closest papers

Nearest neighbours by meaning across the whole index.

Intervention-Aware Clinical World Model for Post-Op Outcome Forecasting in Cardiology

cs.LG cs.CV ·2026-08-13 ·Yunsung Chung, Yingshuo Liu, Abboud F. Hassan, Han Feng, Mary M. Maleckar +2 more
published similarity 0.70
Abstract · Medical World Models (MWM) Workshop at MICCAI 2026

Many clinical prediction models treat post-intervention outcomes as a one-step mapping from baseline measurements to a future endpoint. However, recovery after a procedure often unfolds as an irregular trajectory: clinical observations, medication changes, repeat interventions, and physiological measurements are recorded asynchronously and can change risk assessment over time. We propose an intervention-aware clinical world model that represents each patient with a structured latent state and evolves it through time-ordered post-intervention events. The model first encodes baseline imaging into a 3D spatial latent state. It then updates this state using procedural context, static covariates, elapsed time, and peri-event physiological embeddings. Follow-up imaging provides training-only supervision through a latent forecasting objective. We apply the framework to atrial fibrillation ablation. During the 90-day recovery window, irregular post-procedure records provide clinically meaningful evidence for long-term recurrence risk. In repeated internal cross-validation on DECAAF-II, our model achieves AUROC 0.756 and AUPRC 0.777 for recurrence prediction. It also achieves a scar-extent MAE of 2.971 percentage points without requiring follow-up MRI intensities at inference. The learned state supports recurrence-risk queries at different horizons and retrospective input editing of blanking-period records.

0.46

Observation-Anchored Selective Assimilation for Longitudinal Tumor-State Proxy Forecasting in Post-Treatment Glioma

cs.LG cs.AI ·2026-09-11 ·Yeonjae Jung, Minwoo Shin
code/data similarity 0.67
Abstract

Post-treatment MRI in patients with glioma provides serial observations for updating patient-specific tumor-state proxy estimates, but variable appearances and trajectories complicate forecasting. We formulate forecasting as an observation-aware digital-twin update in which an intermediate observation anchors the patient-specific state. Among 203 patients and 594 follow-up time points, a predefined no-new-treatment criterion retained 120 of 236 candidate triplets, split into 81/24/15 training/validation/test triplets at the patient level. Each time point was represented by a continuous voxel-wise tumor-state proxy map in [0,1] derived from MRI lesion labels. A SegMamba-based single-step forecaster predicted update proposals from multimodal source-state tensors. Observation-Anchored Selective Assimilation (OASA) retained the observed intermediate proxy as the state anchor and selectively applied updates through a validation-selected tiered case-level rule and voxel-wise soft gate. We compared initial-scan forecasting, rollout without assimilation, latest-observation persistence, direct prediction, OASA, OASA + calibration, and morphological dilation. Checkpoints, OASA rules, and calibration thresholds were selected using validation data only. Across three seeds on 15 held-out test triplets, OASA maintained Dice at $τ$ = 0.2 comparable to persistence (0.6071 $\pm$ 0.0025 vs. 0.6070) while yielding numerically higher Dice at $τ$ = 0.5 (0.4269 $\pm$ 0.0079 vs. 0.3981), with a small RMSE increase. Calibration increased Dice at $τ$ = 0.2 to 0.6178 $\pm$ 0.0025, increased false-positive (FP) support (11,836$\rightarrow$18,663), and reduced false-negative (FN) support (22,107$\rightarrow$17,536). This reflects near-threshold support calibration rather than improved biological predictive capability. Code is publicly available at https://github.com/jsudg436/longitudinal-proxy-forecasting.

0.29

Repeated-Measure Leakage, Distribution Shift, and Reliability under Partial Observation in Patient World Models

cs.LG ·2026-10-03 ·Arjun Subramanian
publishedcode/data similarity 0.67
Abstract · 13 pages, 7 figures. Selected for oral presentation at the NeurIPS 2026 Workshop on World Models for High-Stakes Health (WMHS) Replication P…

Patient world models are increasingly proposed for longitudinal prediction, intervention-aware reasoning, and clinical-trial simulation. Causal or clinical intervention validity is distinct from predictive generalization and reliability; before making stronger claims, the underlying predictive state should generalize across patients, survive realistic shifts and missing observations, and expose failure through meaningful reliability signals. We evaluate these prerequisites in a deliberately narrow setting: short-horizon digital-biomarker forecasting from PhysioNet GaitPDB, comprising 165 participants, 306 recordings, and 51,129 context-future pairs. Using persistence, ridge, MLP, GRU, Transformer, and a compact JEPA-style predictor, we build an evaluation ladder that progressively removes raw temporal overlap, same-recording familiarity, and same-patient familiarity before testing unseen-patient generalization. For GRU, NMSE rises from 0.1227 under random-window splitting to 0.1393 after eliminating raw train-test overlap and to 0.1961 under patient holdout. Among 54 participants with repeated recordings, exposure to a different recording from the same patient improves GRU NMSE from 0.2177 to 0.1556, while a recording-excluded identity hypothesis is not supported at the participant level. Under participant-held-out evaluation, MLP and Transformer are statistically indistinguishable. Study shift, a four-times-longer prediction gap, and partial observation further degrade performance; under 50% temporal masking, Transformer NMSE rises to 0.611 while MC-dropout predictive variance falls. We do not claim a longitudinal or intervention-aware simulator. Instead, the results support a prerequisite evaluation stack of patient separation, repeated-measure controls, shift, missingness, and uncertainty validation before stronger patient-world-model claims are trusted.

0.39

Causal multi-modal AI for personalized chemosensitivity prediction

cs.AI ·2026-09-11 ·Dhruva Biswas, Jeroen Berrevoets, Alec McClean, Linus Bao, Jungkyu Park +29 more
highly cited similarity 0.64
Abstract

Chemotherapy improves survival for some patients with breast cancer, but doctors cannot reliably predict who. Current guidelines rely on recurrence scores as a proxy for treatment benefit, which may contribute to the overprescription of chemotherapy. Here we present a causal multi-modal AI model that predicts personalized chemosensitivity using routinely collected pathology and clinical information. We developed our model on a multi-national dataset of 9,141 patients (twelve cohorts, nine countries) and evaluated it on another 1,994 patients (five cohorts, three countries). The model generated treatment-specific recurrence probabilities for each patient, with near-perfect calibration and strong prognostic discrimination across both 5- and 10-year follow-up horizons. Moreover, its chemotherapy benefit predictions demonstrated robust predictive performance, and out-performed existing recurrence-score-based tests. Compared to the standard of care, using the model to support personally tailored therapeutic decisions could reduce the number of patients receiving chemotherapy by 30% while achieving the same recurrence-free rate. Tumors predicted to be highly chemosensitive displayed concordant molecular and morphological programs of proliferation, cell cycle progression, and replication stress. The model's predictive capabilities transferred zero-shot to non-breast cancers, indicating our causal multi-modal AI approach may provide a universal strategy to predict treatment outcomes across cancer types.

0.52

CoRe-WM: Conditioned Response-State World Modeling for Longitudinal Treatment-Response Prediction in Breast DCE-MRI

cs.CV ·2026-10-18 ·Lin Zhao, Bowen Chen, Qiaohui Gao, Shaowen Wan, Xiang Li +2 more
similarity 0.63
Abstract

Pathologic complete response (pCR) after neoadjuvant chemotherapy is a key prognostic indicator in aggressive breast cancer, yet existing prediction approaches either rely on pretreatment imaging alone, missing the patient's evolving response, or optimize multi-visit classifiers under direct outcome supervision, coupling representation learning with the clinical endpoint. We formulate longitudinal pCR prediction as a world-modeling problem and propose Conditioned Response-state World Modeling (CoRe-WM), which learns a latent state-transition model that predicts the next imaging state from the observed sequence. The transition function is conditioned on patient clinical profile and assigned therapy through additive shift and feature-wise modulation, enabling patient- and treatment-specific dynamics. A Factorized Response State pathway further decouples treatment-response dynamics from imaging appearance by encoding the structural prior that response manifests primarily in lesion morphology. After pretraining, all parameters are frozen and a linear readout predicts pCR at each clinical decision point. We evaluate CoRe-WM on I-SPY2 under five-fold cross-validation and assess cross-cohort transfer on I-SPY1. CoRe-WM achieves the highest discrimination among all evaluated methods at every prospective decision point, and demonstrates robust cross-cohort transfer. Ablation studies identify patient-profile conditioning and the factorized response pathway as the principal contributors. These results establish world-model-based representation learning as a promising framework for outcome prediction in oncology and beyond.

0.20

A Patient World Model for Early Forecasting of Digital Health Campaign Outcomes: Capabilities and Limits

cs.LG cs.AI ·2026-09-20 ·Yunlong Wang
similarity 0.63
Abstract · 17 pages including supplementary

Digital direct-to-consumer (DTC) health campaigns are usually measured after the fact. In-flight forecasting commonly relies on a separate classifier for every cutoff and horizon. We treat this task as a dynamic-system problem and build a compact patient world model. The architecture maintains a latent state per patient, learns exposure-conditioned state dynamics jointly with a weekly conversion hazard, and rolls forward into future conversion curves. We evaluate it on a US campaign dataset with 147{,}173 patients and 5.2 million at-risk person-weeks. In a retrospective evaluation conditioned on recorded future exposures, the model forecasts the remaining new-to-brand prescription volume through week 52 with a relative error of 2.9\% from a week-4 cutoff and 0.8--2.6\% from cutoffs at weeks 8--26. The strongest non-recurrent baseline, a pooled-hazard gradient boosting model given the same survival rollout and information, has relative errors of 13.6--33.1\%. Per-horizon classifiers perform substantially worse. A Fisher-information analysis motivates dense next-exposure supervision when conversions are rare. Removing this auxiliary objective increases prescription-volume error by approximately $2$--$14\times$, while providing no consistent disadvantage on the more common specialist-visit outcome. We also evaluate scenario simulation. Switching all future exposure off raises predicted conversion from 0.31 to 0.89, a pattern consistent with selection effects in observational exposure data. This result highlights the limits of interpreting exposure-conditioned rollouts causally.

0.23

PGP-Clinical-TimeKAN: Prior-Guided Joint Probabilistic Forecasting of Clinical Trajectories

cs.AI ·2026-08-24 ·Weizhi Nie, Rihao Chang, Weijie Wang, Yuting Su
similarity 0.63
Abstract · 30 pages, 12 figures, and 17 tables

Clinical deterioration unfolds through coupled, partially observed trajectories, not a single diagnostic label. We introduce PGP-Clinical-TimeKAN, a trajectory-first framework for joint probabilistic forecasting of multivariate physiology. It combines missingness-aware temporal encoders, a soft organ-system prior, patient-specific relations, nonlinear Kolmogorov-Arnold messages, and a low-rank multivariate Student-t head. We evaluate 24-hour histories and six-hour forecasts on a frozen MIMIC-IV-derived cohort of 6,882 patients and 54,694 windows. Across five seeds and 13 models, PGP-Clinical-TimeKAN obtains the second-lowest normalized MAE (0.37727 +/- 0.00029) and the lowest RMSE (0.52656 +/- 0.00034). It reduces MAE by 0.52% relative to deterministic TimeKAN. For probabilistic forecasting, it reaches a marginal NLL of 0.66380 and a CRPS of 0.27301. Empirical coverage is 0.533, 0.831, and 0.958 for nominal 50%, 80%, and 95% intervals. Removing relational structure causes the largest ablation loss. Increasing covariance rank improves joint likelihood but has little effect on point accuracy. A trajectory-derived risk score remains weaker than a dedicated GRU-D classifier (AUROC 0.603 versus 0.650), which limits the present clinical claim. Joint trajectory forecasting therefore provides an inspectable intermediate task, but accurate physiology forecasts alone do not ensure a calibrated event detector.

0.15

The Predictability Bias of Joint-Embedding Predictive Learning in Medical Imaging

eess.IV cs.CVcs.LG ·2026-10-09 ·Fabian Drexel, Bernhard Kainz, Jakob N. Kather, Daniel Rueckert, Lisa C. Adams +2 more
similarity 0.62
Abstract · 45 pages, 6 figures

Joint-embedding predictive architectures (JEPAs) learn by predicting teacher representations of masked regions from visible context. Point prediction summarizes the conditional target distribution and cannot reproduce variation that the context does not resolve. We call this constraint predictability bias. In computed tomography (CT), recurrent anatomy is predictable from context, whereas the sporadic, localized pathology that determines clinical interpretation often is not. We introduce TAP-JEPA, a ViT-B/3D trained on 113,611 CT volumes that is competitive with state-of-the-art encoders (COLIPRI, Merlin, VoxelFM) in scan-level classification. We then audit the learned predictive pathway by replaying the exact masking, teacher, and predictor computations used during training. Prediction lowers the mean Skill (prevalence-normalized average precision) from 0.388 to 0.271 for pathology, but only from 0.921 to 0.873 for anatomy. Along the teacher direction, separating pathology from matched control regions in the same organ, prediction moves pathology 34.7% toward the controls and controls 13.6% toward pathology, with larger shifts farther from visible context. Replacing visible matched-control representations increases surrounding-target prediction loss more than fully replacing pathology representations across four pathology categories. Downstream, removing all final-layer pathology tokens reduces the decision margin by at most 0.45% in four of seven scan-level probes. Together, these results show that contextual predictability is not a sufficient proxy for clinical relevance in medical representation learning. Training objectives should therefore retain diagnostic features regardless of their predictability from surrounding anatomy.

0.19